AptarGroup, Inc.

AI-generated fair value estimate for this company.

Method: 10-year two-stage unlevered FCF DCF: $312M normalized FCF base (3-year average FY2023-FY2025 FCF); 7.5% annual FCF growth years 1-5; 4.5% years 6-10; 8.5% discount rate (WACC); 2.5% terminal growth; $1.07B net debt; 63.5M diluted shares outstanding.

Reasoning: Aptar is a mature, cash-generative packaging/dispensing company with a capex-heavy Pharma expansion phase, so a normalized 3-year-average FCF base smooths capex-cycle volatility better than a single-year snapshot, with growth tapering from near-term Pharma-driven acceleration to steady-state industrial growth.